Science to practice: Can intravoxel incoherent motion diffusion-weighted MR imaging be used to assess tumor response to antivascular drugs?

Radiology

Volumn 272, Issue 2, 2014, Pages 307-308

  Koh, Dow Mu ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CKD 516; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

ARTICLE; CLINICAL PRACTICE; COLLAPSE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE PROCESSING; INTRAVOXEL INCOHERENT MOTION ANALYSIS; LIVER CELL CARCINOMA; LIVER TUMOR; MOTION ANALYSIS SYSTEM; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPRODUCIBILITY; SCIENCE; SIGNAL NOISE RATIO; TREATMENT RESPONSE; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; BENZOPHENONES; DIFFUSION MAGNETIC RESONANCE IMAGING; LIVER NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; VALINE;

EID: 84905059652     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14140714     Document Type: Article

References (7)

1. Joo I, Lee JM, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors. Radiology 2014;272(2):417-426.
2. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505.
3. Thoeny HC, De Keyzer F, Vandecaveye V, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005;237(2):492-499. (Pubitemid 41507886)
4. Chen F, De Keyzer F, Feng YB, et al. Separate calculation of DW-MRI in assessing therapeutic effect in liver tumors in rats. World J Gastroenterol 2013;19(47):9092-9103.
5. Andreou A, Koh DM, Collins DJ, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 2013;23(2):428-434.
6. Kakite S, Dyvorne H, Besa C, et al. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging 2014 Jan 10. [Epub ahead of print]
7. Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 2009;19(11):2728-2738.